PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
24-Jan-2025 Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%) aap Implantate AG
23-Jan-2025 Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress ABIVAX
23-Jan-2025 Keith Hale appointed as Group CEO to Unite Titian Software & Labguru (BioData) Titian Software / Labguru
23-Jan-2025 ANGLE plc: TRADING UPDATE ANGLE plc
23-Jan-2025 Phacilitate Awards Katherine High with the 2025 Lifetime Achievement Award at the Advanced Therapies Awards Ceremony in Dallas Phacilitate
23-Jan-2025 Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care Roche
23-Jan-2025 Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors Galenica AG
23-Jan-2025 Galenica reports strong sales growth once again Galenica AG
22-Jan-2025 2.5 Million Grant Awarded to Indiana University School of Medicine, Beckman Coulter Life Sciences to Expand Leukemia and Lymphoma Testing in Africa Beckman Coulter Life Sciences
22-Jan-2025 OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel OGT
22-Jan-2025 OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding OKYO Pharma
22-Jan-2025 Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice Drägerwerk AG & Co. KGaA
22-Jan-2025 ASTRAZENECA RECEIVES TWO POSITIVE NICE RECOMMENDATIONS FOR LUNG CANCER PATIENTS ACROSS ENGLAND AND WALES ASTRAZENECA
22-Jan-2025 Next-generation concepts accelerate progress for sustainable packaging at Henkel’s first DESIGNathon Henkel Adhesive Technologies
22-Jan-2025 ENA Respiratory Successfully Completes Phase Ib Dosing of Antiviral Host Defense Immune Enhancer INNA-051 Dry Powder Formulation in Older Adults and Advances Study in Young Adults ENA Respiratory
22-Jan-2025 Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma Sanofi
22-Jan-2025 Cambridge Cognition expands services with the launch of in-house Rater Training Cambridge Cognition
22-Jan-2025 AlzeCure receives abstract acceptance at Alzheimer’s congress AD/PD 2025 on NeuroRestore ACD856 receives abstract acceptance at Alzheimer’s congress AD/PD 2025 on NeuroRestore ACD856 AlzeCure
22-Jan-2025 Chiesi Study Highlights Challenge of Incorrect Use of Inhalers in the UK Chiesi UK & Ireland
22-Jan-2025 Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer Pharming